







ACTH (1-39)
ACTH (1-39) from Super Human Peptides UK is the full-length, 39-amino acid synthetic analogue of human Adrenocorticotropic Hormone. Endogenously produced and secreted by the anterior pituitary gland, it is the primary biological driver of the body’s systemic stress response. In laboratory research, ACTH (1-39) is the foundational model for investigating the Hypothalamic-Pituitary-Adrenal (HPA) axis.
Unlike truncated cognitive fragments (such as ACTH 4-10 or Semax), the full 1-39 sequence is required to bind specifically to the Melanocortin 2 Receptor (MC2R) located on the adrenal cortex. Researchers utilize this full-length peptide to study the direct pharmacological stimulation of the adrenal glands, resulting in the secretion of glucocorticoids (like cortisol) and mineralocorticoids. Produced under GMP-compliant conditions and verified for 99% purity or higher, ACTH (1-39) is a critical tool for advanced research into adrenal insufficiency, systemic stress-response pathways, and complex neuroendocrine feedback loops.
- —Full-Length Sequence: The complete 39-amino acid chain identical to endogenous human ACTH.
- —HPA Axis Modulator: The master regulator of the hypothalamic-pituitary-adrenal stress pathway.
- —MC2R Specificity: Specifically binds to the Melanocortin 2 Receptor to trigger adrenal steroidogenesis.
- —Systemic Application: Utilized to test full adrenal capacity rather than isolated neurological effects.
- —High Purity: 99% purity or higher (verified by HPLC and MS analysis).
- —Quality Standard: GMP / ISO certified manufacturing.
- —Adrenal Steroidogenesis: Studying the intracellular signaling pathways that convert cholesterol into active glucocorticoids following MC2R activation.
- —HPA Axis Integrity: Preclinical models utilizing ACTH challenge tests to measure adrenal reserve and identify secondary vs. primary adrenal insufficiency.
- —Circadian Rhythms: Investigating the peptide's role in the naturally occurring "cortisol awakening response" and physiological synchronization.
- —Stress Response Pathways: Researching the systemic metabolic adaptations (such as lipolysis and glycogenolysis) triggered by profound, acute ACTH surges.
- —Melanocortin Receptor Mapping: Evaluating the binding affinity and cross-reactivity of the full-length peptide across all five known melanocortin receptors (MC1R-MC5R).
ACTH was one of the earliest polypeptide hormones to be fully sequenced, fundamentally shaping our modern understanding of endocrinology. Landmark laboratory studies demonstrated that the first 24 amino acids (ACTH 1-24) contain the primary biological activity, but the full 1-39 sequence provides the extreme stability and precise receptor specificity seen in natural biological systems. In laboratory settings, administering ACTH (1-39) induces a rapid, dose-dependent release of corticosteroids from the adrenal cortex.
Because it bypasses the hypothalamus and directly targets the adrenal glands, it is the universal gold standard for testing adrenal function. Animal models treated with full-length ACTH exhibit profound metabolic shifts necessary for survival under acute stress, including elevated blood glucose, immune system modulation, and profound anti-inflammatory cascades. Due to its systemic power, it is strictly utilized to map the upper limits of endocrine capacity and severe stress-adaptation mechanisms.


